Table 2.
Symptoms observed at baseline: frequency and severity (0–10 points of a NRS) compared by study group.
| Symptom | Study group |
N Placebo (n = 87) Domperidone (n = 86) |
Percentage of patients presenting the symptom (%) | Symptom severity mean (SD) | p value for symptom severity comparison |
|---|---|---|---|---|---|
| Fever | Placebo | 41 | 47.7 | – | |
| Domperidone | 41 | 47.1 | – | ||
| Cough | Placebo | 67 | 77.9 | 5.30 (2.30) | 0.705 |
| Domperidone | 68 | 78.2 | 5.44 (2.08) | ||
| Odynophagia | Placebo | 53 | 61.6 | 5.70 (2.30) | 0.645 |
| Domperidone | 50 | 57.5 | 5.48 (2.48) | ||
| Dyspnoea | Placebo | 7 | 8.1 | 3.71 (2.29) | 0.353 |
| Domperidone | 4 | 4.6 | 5.00 (1.63) | ||
| Chest pain | Placebo | 8 | 9.3 | 5.75 (2.87) | 0.562 |
| Domperidone | 13 | 14.9 | 6.39 (2.06) | ||
| Chills | Placebo | 17 | 19.8 | 5.65 (2.03) | 0.574 |
| Domperidone | 17 | 19.5 | 5.24 (2.19) | ||
| Nausea | Placebo | 11 | 12.8 | 4.27 (2.53) | 0.157 |
| Domperidone | 13 | 14.9 | 5.77 (2.45) | ||
| Vomiting | Placebo | 3 | 3.5 | 5.00 (4.36) | 0.615 |
| Domperidone | 2 | 2.3 | 3.00 (2.83) | ||
| Diarrhoea | Placebo | 11 | 12.8 | 5.91 (2.43) | 0.563 |
| Domperidone | 10 | 11.5 | 5.20 (3.08) | ||
| Abdominal pain | Placebo | 2 | 2.3 | 5.00 (4.24) | 0.637 |
| Domperidone | 5 | 5.8 | 6.20 (2.39) | ||
| Nasal congestion | Placebo | 54 | 62.8 | 6.06 (2.24) | 0.095 |
| Domperidone | 50 | 57.5 | 6.76 (2.02) | ||
| Anosmia | Placebo | 6 | 7 | 7.17 (2.93) | 0.903 |
| Domperidone | 9 | 10.3 | 7.33 (2.29) | ||
| Dysgeusia | Placebo | 3 | 3.5 | 6.33 (3.06) | 0.963 |
| Domperidone | 12 | 13.8 | 6.42 (2.68) | ||
| Headache | Placebo | 55 | 64 | 6.35 (2.15) | 0.466 |
| Domperidone | 54 | 62.1 | 6.04 (2.25) | ||
| Myalgia | Placebo | 39 | 45.4 | 6.77 (2.06) | 0.996 |
| Domperidone | 35 | 40.2 | 6.77 (2.17) | ||
| Arthralgia | Placebo | 13 | 15.1 | 7.00 (2.20) | 0.191 |
| Domperidone | 20 | 23 | 5.85 (2.54) | ||
| Weariness | Placebo | 51 | 59.3 | 6.98 (2.06) | 0.167 |
| Domperidone | 53 | 60.9 | 6.34 (2.59) | ||
| Weakness | Placebo | 22 | 25.6 | 6.55 (1.84) | 0.781 |
| Domperidone | 24 | 27.6 | 6.38 (2.24) | ||
| Anorexia | Placebo | 18 | 20.9 | 6.67 (2.09) | 0.087 |
| Domperidone | 16 | 18.4 | 7.81 (1.64) | ||
| Dizziness | Placebo | 9 | 10.5 | 5.44 (2.56) | 0.775 |
| Domperidone | 6 | 6.9 | 5.83 (2.48) | ||
| Vertigo | Placebo | 0 | 0 | – | – |
| Domperidone | 1 | 1.2 | 3.00 | ||
| Anxiety | Placebo | 1 | 1.2 | 6.00 | – |
| Domperidone | 0 | 0 | – | ||
| Insomnia | Placebo | 3 | 3.5 | 6.00 (1.73) | 0.768 |
| Domperidone | 3 | 3.5 | 7.00 (5.20) | ||
| Facial pain | Placebo | 1 | 1.2 | 10.00 | 0.317 |
| Domperidone | 3 | 3.5 | 7.67 (1.53) | ||
| Dysphonia | Placebo | 5 | 5.8 | 5.00 (2.00) | 0.581 |
| Domperidone | 10 | 11.5 | 5.70 (2.36) | ||
| Otalgia | Placebo | 3 | 3.5 | 6.67 (0.58) | 0.004 |
| Domperidone | 2 | 2.3 | 10.00 (0.01) | ||
| Dry eye | Placebo | 1 | 1.2 | 7.00 | – |
| Domperidone | 0 | 0 | – | ||
| Blurred vision | Placebo | 1 | 1.2 | 6.00 | – |
| Domperidone | 1 | 1.2 | 5.00 | ||
| Foreign body sensation | Placebo | 2 | 2.3 | 6.00 (1.41) | – |
| Domperidone | 0 | 0 | – | ||
| Conjunctival congestion | Placebo | 1 | 1.2 | 9.00 | 0.454 |
| Domperidone | 2 | 2.30 | 7.00 (1.41) |